Transmission
routes
of
respiratory
viruses
among
humans
Jasmin
S
Kutter
1,3,
Monique
I
Spronken
1,3,
Pieter
L
Fraaij
1,2,
Ron
AM
Fouchier
1and
Sander
Herfst
1Respiratorytractinfectionscanbecausedbyawidevarietyof viruses.Airbornetransmissionviadropletsandaerosols enablessomeofthesevirusestospreadefficientlyamong humans,causingoutbreaksthataredifficulttocontrol.Many outbreakshavebeeninvestigatedretrospectivelytostudythe possibleroutesofinter-humanvirustransmission.Theresults ofthesestudiesareofteninconclusiveandatthesametime datafromcontrolledexperimentsissparse.Therefore, fundamentalknowledgeontransmissionroutesthatcouldbe usedtoimproveinterventionstrategiesisstillmissing.Wehere presentanoverviewoftheavailabledatafromexperimental andobservationalstudiesonthetransmissionroutesof respiratoryvirusesbetweenhumans,identifyknowledgegaps, anddiscusshowtheavailableknowledgeiscurrently implementedinisolationguidelinesinhealthcaresettings.
Addresses
1
DepartmentofViroscience,PostgraduateSchoolofMolecular Medicine,ErasmusMedicalCentre,Rotterdam,TheNetherlands
2DepartmentofPediatrics,SubdivisionInfectiousdiseasesand
Immunology,ErasmusMedicalCentre–Sophia,Rotterdam,The Netherlands
Correspondingauthor:Herfst,Sander(s.herfst@erasmusmc.nl)
3Theseauthorscontributedequallytothiswork.
CurrentOpinioninVirology2018,28:142–151
ThisreviewcomesfromathemedissueonEmergingviruses: intraspeciestransmission
EditedbySanderHerfstandMartinLudlow
ForacompleteoverviewseetheIssueandtheEditorial Availableonline17thJanuary2018
https://doi.org/10.1016/j.coviro.2018.01.001
1879-6257/ã2018TheAuthors.PublishedbyElsevierB.V.Thisisan openaccessarticleundertheCCBY-NC-NDlicense( http://creative-commons.org/licenses/by-nc-nd/4.0/).
Introduction
Viral respiratory tract infections are a leading cause of
morbidityandmortalityworldwide,representingan
enor-mous economic and disease burden [1]. Respiratory
virusesreplicateintherespiratorytractfromwherethey
are subsequently shed and transmitted via respiratory
secretions.Theyareclassifiedindifferentvirusfamilies
anddifferinvirulenceandtargetgroups.Respiratorytract
infections may range from asymptomatic to acute live
threatingdiseasetherebyposingamajorhealththreatto
young children, elderly, and immunocompromised
people. Respiratory viruses spread via three different
transmissionroutes: contact (director indirect),droplet
and aerosol transmission(Table 1)[2,3]. Contact
trans-mission refers to direct virus transfer from an infected
persontoasusceptibleindividual(e.g.viacontaminated
hands)orindirectvirustransferviaintermediateobjects
(fomites).Transmissionofvirusthroughtheaircanoccur
viadropletsoraerosols.Thecommonlyacceptedcut-off
size between the large droplets and small aerosols is
5mm,althoughthisvariesconsiderablybetweenstudies,
ranging up to 12mm [4–8]. Droplets generated during
coughing,sneezingortalkingdonotremainsuspendedin
airandtravellessthan1mbeforesettlingonthemucosa
ofclosecontactsorenvironmentalsurfaces.Aerosolshave
aslow settling velocity,thus theyremain suspended in
theairlongerandcantravelfurther[5,9,10].
Transmissionvia eachof these three routesis complex
and depends on many variables such as environmental
factors (e.g. humidity and temperature), crowding of
people,butalsoonhostfactorssuchasreceptor
distribu-tion throughout the respiratory tract. The fact that all
thesevariablesaffectthedifferenttransmissionroutesof
thedifferentrespiratoryvirusesinadissimilarway,makes
itverydifficulttoinvestigatethemexperimentally[9,11].
Here,wesummarizetheevidencefromexperimentaland
observationalstudiesoninter-humantransmissionroutes
ofimportantrespiratoryviruses(summarizedinTable2).
A literature search was conducted for each respiratory
virus using ‘human transmission experiments’ and
‘transmission (routes)’ of the virusof interest as search
criteria in PubMed and Google Scholar. Subsequently,
the backward snowball method was applied in which
additionalpaperswereidentifiedbasedonthereference
listof apaperofinterest. Asthis review focusesonthe
evidenceoninter-humantransmissionroutes,datafrom
animal studieswereexcluded.Inaddition, intervention
studies,(aircraft)outbreakreportsandhouseholdstudies
wereexcluded ifthetransmissionroutewas not
specifi-callyinvestigated.Thestrengthsandweaknessesofthe
differentmethodsemployedin transmissionstudiesare
summarizedinTable3.Finally,wediscussourfindingsin
thelightofseveralavailable(inter)nationalguidelineson
infectioncontrol.Ourobservationsunderscoretheurgent
needfornewknowledgeonrespiratoryvirustransmission
routes and the implementation of this knowledge in
infectioncontrolguidelinestoadvanceintervention
strat-egiesforcurrentlycirculatingandnewlyemergingviruses
Measles
virus
(MV)
Measles is one of the mostcontagious viral diseases in
humans thathasbeen associated with aerosol
transmis-sionforalongtime[12,13,14,15–17,18].However,it
shouldbenotedthatMValsoreplicatessystemically,and
that there is arole for dead celldebris-associated virus
spreadviafomites.Inthelate1970sandearly1980s,data
fromretrospectiveobservationalstudiesobtainedduring
outbreaksin pediatricpractices, aschool,andasporting
eventsuggestedtransmissionthroughaerosols[14,15–
17,18].Indeed,thosestudiesshowedthatmost
second-ary cases never came in direct contact with the index
patientandsomewereneverevensimultaneously
pres-entinthesameareaastheindexcase[14,18].
Exami-nationofairflowinthepediatricians’officesshowedthat
aerosolswerenotonly dispersed over theentire
exami-nation room but also accumulated in the hallway and
otherareas[14,18].Furthermore,basedonthe
inves-tigationofaircirculationinasportstadium,inwhichaMV
outbreakoccurred,authors suggestedthatMVhadbeen
dispersed through the ventilation system [16]. Thus it
wasconcludedthatMVcanbetransmittedviaaerosols.
Althoughcoughingisacommonsymptomassociatedwith
measlesdisease,indexpatientsweredescribedtocough
Table1
Commonlyacceptedrespiratoryroutesoftransmission
Transmissionroute Particlesinvolvedandparticlecharacteristics Characteristics/definitionoftransmission
Contact Self-inoculationofmucousmembranesbycontaminatedhands. Direct Depositedonpersons. Virustransferfromoneinfectedpersontoanother.
Indirect Depositedonobjects. Virustransferthroughcontaminatedintermediateobjects(fomites).
Airborne
Droplet Droplets(>5mm).
Remainonlyshortlyinair(<17min)[116]. Dispersedovershortdistances(<1m).
Shortrangetransmission.
Directinoculationofnaı¨ve personthroughcoughing/sneezing/ breathingofinfectedperson.
Depositionmainlyonmucousmembranesandupperrespiratory tract.
Aerosol Aerosols,dropletnuclei(<5mm),
Remaininairforanalmostinfiniteamountoftime. Dispersedoverlongdistances(>1m).
Longrangetransmission.
Inhalationofaerosolsinrespirablesizerange.
Depositionalongtherespiratorytract,includingthelowerairways.
Table2
Overviewoftheevidenceontransmissionroutesofrespiratoryvirusesbasedonexperimentaldataandthetransmissionrouteaccording toinfectionpreventionguidelines
Virus Virusfamilya Transmissionroute
Experimentalandobservationaldata Guidelinesb
Measlesvirus Paramyxoviridae Aerosol[75–77,78,79]. Contact[3,110],droplet[3,109–111], aerosol[3,109–111].
Parainfluenzavirus Paramyxoviridae Limiteddata,contact(byfomite)[83,84]e. Contact[3,109–111],droplet[3,109–111],
aerosol[3,109].
HMPV Pneumoviridae Limiteddata,contact(byfomite)e[30] Contact[3,110,111],droplet[3,110,111].
RSV Pneumoviridae Contact[89,88],droplet[88],aerosol [90,91].
Contact[3,109–111],droplet[3,109,110], aerosol[109,111].
HCoV Coronaviridae Limiteddata,contact(byfomite)[65–67]e. Contact[3,110,111],droplet[3,110,111].
MERS-CoV Coronaviridae Contact[84]e[89]c[91],droplet[89]c,
aerosol[91].
Contact[111],droplet[3,111]
SARS-CoV Coronaviridae Contact[70]e[73,79,101],droplet [73,78,79,117],aerosol[76,118]c[82]c,d.
Contact[3,110,111],droplet[3,110,111], aerosol[3,110,111].
Rhinovirus Picornaviridae Contact[35,36,42],aerosol[37,40,119]. Contact[109–111],droplet[109,111], aerosol[109–111].
Adenovirus Adenoviridae Contact[100]e[100,101],droplet[103],
aerosol[102,103].
Contact[3,109–111],droplet[3,109,110], aerosol[110,111].
Influenzavirus Orthomyxoviridae Droplet/aerosol[55,56,57,59] Contact[109–111],droplet[3,109–111], aerosol[3,109–111].
aTaxonomywasbasedon[62],airbornetransmissionisseeminglylinkedto:
b WIP[108],‘BlueBook’[109],‘RedBook’[110],CDC[3]andUp-To-Date[111].Theconclusionsonexperimentaldataaspresentedinthistable
reflecttheconclusionsfromtheauthors.
c
Superspreaderevents.
d Aerosol-generatingprocedures(inanosocomialsituation). eConclusionsweredrawnbasedonstabilityexperiments.
frequently and vigorously in the outbreak reports of
pediatricpractices.Remingtonetal.calculatedthe
infec-tious dose of MV produced by the index casethrough
coughing,usingamathematicalmodelbasedonairborne
transmission.Theyfoundthattheindexcaseproduceda
very highinfectious dosecompared to cases fromother
outbreaks and mentioned a phenomenon called
super-spreading[18].Superspreadersareindividualswhoare
abletoinfectadisproportionallylargenumberof
suscep-tiblecontactswhencomparedtoatypicalindividual[19–
22],whichmaycontributetotheefficienttransmissionof
MV.
Table3
Overviewofthemethodstostudyhuman-to-humantransmissionandtheirrespectivepro’sandcon’s
Studydesign Pro Con Reference
Virusstability Canprovideindirectevidencefor transmissionroute.
Easytoperform.
Notconclusiveastransmissionitselfisnot investigated.
[42,43,65,70]
Outbreak(householdor hospital)reports
Studynaturalinfections. Includesthemostsusceptible patientswhoaredifficulttoinclude inexperimentalstudies.
Retrospective.
Usuallynotconclusiveontransmissionrouteor relativeimportanceoftransmissionroutes.
[120–123]
Outbreakreport— aircraft
Relativelyeasytoperform Outbreakinclosedsetting
Retrospectivewhichcanresultinrecall-biasand hardtotracebackpassengermovements. Inconclusive.
Onlyreportedincaseofsecondaryinfectionsand inthesecasesinfectionsmayalsooccurbeforeor aftertheflight.
[118,124–127]
Non-pharmaceutical Intervention
Canhelptodiscriminatebetween transmissionroutesifperformed properly.
Usuallynocontrolledenvironment. Difficulttodetermineidealtime-pointofthe intervention.
Riskofdrop-outorperseverance.
[35,128–131]
Pharmaceutical intervention
Canhelptoidentifyrelative importanceoftransmissionroutes Controlledenvironment
Difficulttoincludeenoughpatientstoobtain statisticallysignificantresults
[132]
Experimentalinfection Controlledenvironment. Donorselectionandcontrol. Real-timedatacollection. Repeatable.
Variousparameterscanbestudied atthesametime.
Possibilitytostudydifferent inoculationroutes.
Ethicalobstacles.
Infectivityanddiseasecandifferfromthatina naturalinfection(attenuatedstrains).
Difficulttocreateidealandcomparable circumstances.
Manyfactorshavetobetakenintoaccount: duration,influenceofsuperspreaders,sampling methods.
Difficulttogetnaı¨ve orriskgroupparticipants whoareinterestingtostudy.
[42,44,102]
Miniaturefieldtrial Candiscriminatebetweencontact andairbornetransmission.
Ethicalobstacles.
Exposuretimemaynotbesufficient. Difficulttocreateidealandcomparable circumstances.
[38,39,40]
Airsampling Noninvasiveforpatients. Quantificationofviablevirusinthe air.
Characterizationofdroplet/ aerosolsize.
Canbeusedinparallelwithhuman studiesoroutbreaks.
Cangaininformationonpossible aerosolspread.
Inanosocomialsettingaerosol-generating procedurescanplayamajorrole.
FrequentlyonlydetectionbyPCR. Directhuman-to-humantransmissionisnot studied(circumstantial).
Technicalissues(proceduremayaffectvirus viability)orfalseinterpretation.
[34,37,57,91,103,133] Airtracerstudies Monitoringairflowpatterncan
indicatepossibleairborne transmission(ifnotdone retrospectively). Visualizeairstream
Usuallyperformedretrospectivelyandnotduring outbreaks [134,135] Computational Modeling/Simulation Describestransmissionina greatercontext.
Canaccountforheterogeneityof transmissionwithinapopulation. Humanmannequinscanbeused asreplacementforhumans
Theoretical(formathematicalmodeling). Artificialsetting.
Parainfluenza
(PIV)
and
human
metapneumovirus
(HMPV)
Thereisasubstantiallackof(experimental)evidenceon
the transmissionroutes of PIV (types1–4) and HMPV.
For both viruses, contact and droplet transmission are
commonly accepted transmission routes [23–25].
How-ever, only virus stability on various surfaces has been
investigated so farand it hasbeen shown thatPIV and
HMPV are stable on non-absorptive surfaces and can
barely berecovered fromabsorptivesurfaces[26–30].
Respiratory
syncytial
virus
(RSV)
TransmissionofRSVamonghumansisthoughttooccur
viadropletsandfomites[1,7].Inthe1980sthreepotential
transmission routes of RSVwere studied in humansby
dividing infected infants and healthy volunteers into
three groups, representing: Firstly, all transmission
routes, secondly, transmission via fomites and finally,
airbornetransmissionbyallowingthevolunteerstohave
either,firstly, directcontactwithinfants(cuddlers),
sec-ondly, touching potential fomites (touchers) or finally,
sittingnexttotheinfant(sitters).Volunteersinthegroup
of thecuddlersandtouchersbut notthesitters became
infected,suggestingthatdirectcontactanddroplet
trans-missionweretheprobableroutesforefficientinfectionof
thevolunteersandthattransmissionviaaerosolswasless
likely[31].Anotherstudyonthetransmissionviafomites
showedthatRSVcouldberecoveredfromcountertopsfor
severalhours, butonly forseveralminutesfrom
absorp-tivesurfacessuchaspapertissueandskin[32].Lateron,
inthelate1990s,Aintablianetal.detectedRSVRNAin
theairupto7mawayfromapatient’shead[33].Inspite
ofthat,sincevirusinfectivitycouldnotbedemonstrated,
potentialairbornetransmissionof RSVhasbeen
consid-ered negligibleandtransmissionofRSVwas thoughtto
occur mainly throughcontact and droplet transmission.
However, inarecentstudyauthors wereableto collect
aerosols thatcontained viable virusfromtheair around
RSVinfected children[34].Althoughthedetectionof
viable virusintheairisbyitselfnotenoughto confirm
aerosol transmission,thegeneralpresumption thatRSV
exclusivelytransmitsviadropletsshouldbereconsidered
and exploredfurther.
Rhinovirus
Extensive human rhinovirus transmission experiments
havenotledtoawidely-acceptedviewonthe
transmis-sion route [35–37,38,39,40]. Inhalation of aerosols
(0.2–3mm) resulted in efficient rhinovirus infection
[41],butlittletonoinfectiousrhinoviruscouldbe
dem-onstrated in sneezes and coughs as detected by virus
titration [42]. Rhinoviruscan surviveon stainless steel,
plasticandskinforacoupleofhours[42,43].Additionally,
virus was detected in saliva, occasionally onhands and
could be recovered from the skin of recipients after
rubbing either a contaminated fomite or hand [42,44].
When rubbing of fomites was followed by
auto-inoculation this resulted in infection of the volunteers
[35].In athree-dayrhinovirusexperiment withhealthy
volunteersdifferentexposuremodeswereusedto
inves-tigate the rhinovirustransmission route: Firsrtly,
small-particleexposure(separatingdonorandrecipientsbywire
mesh), secondly, large particle exposure (encouraging
contact, coughing and sneezing while wearing gloves)
and finally, direct contact exposure (hand contact
fol-lowed byself-inoculation).Fromtheresults it was
con-cluded that direct contact was the main transmission
route [36]. Furthermore, rhinovirus RNA was detected
in offices by air sampling studies and subsequent
sequencing resulted in a matched air-mucus pair [37].
Inaminiaturefieldtrail,experimentallyinfecteddonors
with severecolds participated in acardgame with
sus-ceptible recipients for 12hours [38,39,40]. A
restraining device,preventingtouchingof theheadand
face, was used in the aerosol condition and heavily
contaminatedcardsandexaggeratedhand-to-face
move-ments in the fomite condition. In these experiments
aerosoltransmissionwas suggested[40].
In general, transmissionratesand exposure time varied
betweenstudies, which maycontributeto thedifferent
routesoftransmissionthatwereobserved.Therefore,the
donor-hours of exposure was determined using donors
with severerhinovirusinfections. At200hoursof
expo-sure todonors,transmissionhadoccurredto 50%of the
susceptible recipients, though the transmission route
itselfwasnotinvestigated[38].
Influenza
A
virus
Duetotheseverityoftheyearlyinfluenzaepidemicsand
the potential of zoonotic influenza A viruses to cause
severeoutbreaks,therehavebeenmanystudieson
influ-enzaAvirustransmissionamonghumans.Differentkinds
ofstudies,suchasairsamplingandinterventionstudies,
aswellashumanchallengestudieshavebeenconducted.
In addition, transmission events have been described
extensively after outbreaks in aircrafts, households and
hospital settings. However, until today, results on the
relativeimportanceofdropletandaerosoltransmissionof
influenza virusesstayinconclusiveand hence,thereare
manyreviewsintensivelydiscussingthisissue[10,45–50].
Alreadyinthemid-1900shumanchallengemodelswere
used to assess the transmission route of influenza virus
[51,52–54].Itwasshownthatillnessoutcomeis
depen-dentontheinoculationrouteandtendsto bemilderin
intranasally infected volunteersin comparison to
inocu-lation through inhalation [52,53]. Furthermore, illness
seemed to be milderin experimentally infected
volun-teersthaninnaturallyinfectedindividuals[51].
Increas-ing numbers of studies focused on the detection and
quantification of influenzaviruses containedin droplets
and aerosols expelled into the air through breathing,
[9,55–56,57,58–61].InfluenzavirusRNAwasdetectedin
theairupto3.7mawayfrompatientswiththemajorityof
viralRNAcontainedinaerosols(<5mm)[59].The
pres-enceofvirusinaerosolscouldindicatepotentialairborne
transmission,althoughmanystudiesonly quantifiedthe
amountofviralRNA[55,57,61].Afewstudiesquantified
viable virus, although this was only recovered from a
minorityofsamples[9,58,59].
Coronavirus
In humans, alpha (229E and NL63) and beta
corona-viruses(OC43,HKU1,SARSandMERS)areassociated
withrespiratorydisease[62,63].Alphacoronaviruseshave
ahighattack rateearlyin lifeandspread rapidlyduring
outbreaks,indicatingefficienthumantohuman
transmis-sion[63].Furthermore,samplesobtainedfromstaffand
patientsof aneonatal and pediatricintensive careunit
showedahighincidenceofhumancoronaviruses
HCoV-229E and HCoV-OC43, suggesting staff-to-patient and
patient-to-stafftransmission[64].Unfortunately,thereis
verylittledatatocorroborateontheHCoV-229E,
HCoV-NL63 and HCoV-OC43 transmission routes.
HCoV-OC43,HCoV-229EandHCoV-NL63infectivitywaslost
between 0 and 72hours on non-absorptive surfaces,
althoughit cansurviveseveral days in medium orPBS
[65–67]. Aerosolized HCoV-229E had a half-life of
67hours in a rotating steel drum (at 20C and 50%
relative humidity) [68]. SARS-CoV and MERS-CoV
appearedto have anunusualcapacityto surviveondry
surfacesas comparedto HCoV-229E,HCoV-OC43,and
HCoV-NL63[69,70].
The SARS outbreak was primarilylinkedto healthcare
settings,with49%ofthecaseslinkedtohospitals[71],
mostprobably caused byaerosol-generating procedures
on severely ill patients[72,73]. Aerosol-generating
pro-cedureslike intubation, theuse of continuous
positive-pressureventilationanddrugdeliveryvianebulizersare
likelyto produce‘fine infectiousdroplets’, whichtravel
further than droplets from coughs [74]. Additionally,
superspreading events contributed to the dispersion of
theSARS outbreak[73,75–77],particularlyin theHotel
Metropole and the Prince of Wales Hospital in Hong
Kong[76].Moreover,alinkwithtransmissionto
health-care workers was observed when they were in close
proximity(<1m)to an indexpatient,suggestingdirect
contactordroplettransmission[73,78,79].Airsamples
and swabs from frequently touched surfaces in a room
occupied by a SARS patient tested positive by PCR,
althoughnoviruscouldbecultured fromthesesamples
[80].IntheAmoy gardensoutbreak fecaldroplet
trans-missionwassuggested[81,82].
To date, there is little data on the human-to-human
MERS-CoV transmission route [83]. MERS-CoV
remainedstable on non-absorptivefor 8 up to 48hours
and for 10min at 20C and 40% relative humidity in
aerosols[84].MERS-CoVoutbreaksinhumansare,like
those with SARS-CoV, primarily linked to healthcare
settings, with a link to hospitals in 31% of the cases
[71,85,86] and healthcare associated human-to-human
transmissionwasobserved[87,88].Superspreaderevents
were shown to play an important role in nosocomial
outbreaks[71,89].Viruswasisolatedfromenvironmental
samples in hospital rooms, suggesting direct contact or
fomitetransmission.Moreover, theairbornepotentialof
MERSwasinvestigatedbyairsampleanalysis[90,91].
Viral RNA was detected on the inlet of air ventilation
equipment[90]and viruswasisolated fromairsamples
and surfaces from inaccessible areas like the ventilator
exit,implicatingpotential aerosoltransmission[91].
Adenovirus
Human adenoviruses can cause respiratory disease
(mainly type 1–5, 7, 14 and 21) [92,93], conjunctivitis
orinfantilegastroenteritis(type40and41)[94].Theyare
acommoncauseofrespiratoryillnessandpneumonia in
children[95,96],whereasinfectionsaregenerally
asymp-tomatic in adults [92]. Adenoviruses cause nosocomial
outbreaks, especially in pediatric care facilities, where
theyspreadrapidly[95,97,98].Moreover,adenovirustype
4 and 7 are responsible for large outbreaks of acute
respiratory disease, especially in crowded conditions.
This is illustrated by, for example, outbreaks among
militaryrecruitsforwhichairbornespreadwassuggested
[92,94,99]. It is difficult to eliminate adenovirus from
skin,fomites andenvironmental surfaces[100].An
out-breakinamentalcarefacilitywasprobablyenhancedby
spendingthedaymainlyinacrowdedroomwhilesharing
cigarettes and soda cans, suggesting indirect fomite
spread[101].Inastudypublishedin1966,experimental
infectionswithadenovirusadministeredasaerosols(0.3–
2.5mm) or droplets (15mm) to healthy, male inmates,
resultedininfectionofallvolunteers,althoughthe
result-ing illness resembled a natural infection only in the
aerosol group [102]. During a military training period,
increasednumbersofadenovirusinfectionsoccurredover
time, which correlated with an increased detection of
PCR-positive air filters. Additionally, a correlation
between disease and the extent of ventilation was
observed,withmoreventilationresultinginfewerdisease
cases[103].Inamorerecentstudyin militaryrecruits,
positiveviralDNAsamplesweremainly obtainedfrom
pillows,lockersandrifles,althoughadenovirusDNAwas
also detected in air samples. No consistent correlation
betweenincreased positive environmental samples and
diseasewas observed[104].
Discussion
Studiesonthetransmissionroutesof respiratoryviruses
have been performed since the beginning of the 20th
century [105]. Despite this, the relative importance of
transmissionroutesofrespiratoryvirusesisstill unclear,
environment (e.g.temperatureandhumidity),pathogen
and host [5,19].Differences in virusshedding between
individuals can contribute to the transmissibility rate,
especially in the case of superspreaders [75,106]. In
addition,theSARS-CoVoutbreakhighlightedtheimpact
ofaerosol-generatingproceduresontheincreasedriskof
human-to-human transmission [74,107], demonstrating
that for these procedures additional containment
mea-sures arenecessary.
Inter-human transmissionhasbeenstudiedundermany
different (experimental) conditions. A summary of the
advantages and disadvantages of the different study
designs (Table 3) highlights the difficulty of human
transmissionexperiments.Asaconsequence,contrasting
resultshavebeenobtainedformanyviruses.Thisisalso
reflectedinTable2,summarizingtheexperimentaldata
on inter-human transmission. Besides the difficulty of
performing studies under well-controlled conditions,
another key issue is that often (attenuated) laboratory
strains are studied in healthy adults, which does not
reflect the natural circumstances and target group and
henceinfluencetheoutcomeofthestudies.
Respiratoryvirusesareanimportantcauseofnosocomial
infections, especially in children. Therefore, we
con-sulted the guidelines on infection prevention from
National [108], European [109], American [3,110] and
International[111])organizationsfortheirinformationon
transmission routes (Table 2) and associated isolation
guidelines (Figure 1). Unfortunately, terms and
defini-tions of respiratory transmission routes and isolation
guidelinesarenotalwaysusedinauniformway,leaving
room for personal interpretation.But more importantly,
information on the transmission route does not always
reflecttheisolationguidelines(e.g.forPIVand
rhinovi-rus, Figure 1). As a proxy for transmission route, virus
stabilityis oftenreferredto in theguidelines, however,
thiscanonlyimplyaroleforindirectcontacttransmission
butisbynomeansconclusiveonthetransmissionroute.
Inhospitalsettings,preventionofcontacttransmissionis
generally implementedinstandardinfectionprevention
Fig.1 PIV MV MERS-CoV Lim.exp.data No guideline Aerosol Droplet Contact Lim.exp.data No guideline Aerosol Droplet Contact WIP Blue boo k CDC Red bookUp-to-d ate Experimental WIP Blue book CDC Red b ook Up-to-da te Experimenta l WIP Blu e book CDC Red book Up-to-date
Experimental WIP Blue book
CDC Red book Up-to-date
Experimental WIP Blue book
CDC Red book Up-to-date
Exper imental
SARS-CoV Rhinovirus Adenovirus Influenza virus
HMPV RSV HCoV
Current Opinion in Virology
Isolationguidelinesforrespiratoryvirusinfectionsincomparisontoexperimentalevidenceontransmissionroutes.Isolationguidelinesforall respiratoryvirusesdiscussedinthisreviewfromNational(WorkingGroupInfectionPrevention(WIP)[108],fromtheNetherlandsNationalInstitute forPublicHealthandtheEnvironment(RIVM)),European(‘TheBlueBook’[109]),American(‘TheRedBook’[110]andtheCentersforDisease Control(CDC)[3])andInternational(UpToDate[111])organizationsareshownontheX-axis,togetherwiththeexperimentalevidenceon transmissionroutes(Table2).ThecategoriesontheY-axisarethedifferenttransmissionroutes(contact,dropletoraerosol),theabsenceof guidelinesforinfectionprevention(‘Noguideline’),orthelimitedavailabilityofexperimentaldata(‘Lim.exp.data’).Theinformationshownfor influenzavirusreflectstheguidelinesonseasonalinfluenzavirus.Closedsquares(&):isolationguidelinesfortherespectiverespiratoryvirus. Opensquares(&):guidelinesareonlyforchildren6yearsold.Opencircles():datafromstabilityexperimentsonly.Opentriangles(~):specific CDCguidelinesforHealthcareProfessionals[115](nottheisolationguideline[3]usedinthisreview).
precautions such as stricthand hygiene and cough
eti-quette. It is important to note differences in isolation
guidelinesbetweendifferentorganizations andthelack
ofcorrelationtoscientificdata.Thevariationindescribed
transmission routes and associated isolation guidelines
amongthedifferentorganizationsunderscoresthelackof
convincingdata.
Well-designed human infection studies could be
employed to investigate therole of transmission routes
of respiratory viruses among humans [112].However,
sincehumantransmissionexperimentsarevery
challeng-ing,animaltransmissionmodelscanprovideanattractive
alternativeandshouldbeexploredanddevelopedforall
respiratoryviruses.Insuchexperiments,theinfluenceof
environmentalfactorsontransmissionroutescanalsobe
investigated[113].However,beforeextrapolating
exper-imentally generated data to humans, it is important to
understandthelimitationsofthesemodels,and
appreci-atetheheterogeneityofexperimentalsetupsemployedin
laboratories[114].Furthermore,quantitativedatasuchas
viral load in the air can be obtained by air sampling
methods in various environments, such as hospital
set-tings. Air sampling of viruses is an increasingly used
technologyinanimalandhumanexperiments.However,
whereas most studies rely on the detection of viral
genomecopies,viabilityassayssuch asplaqueassays or
virustitrationshouldbeincludedtogaininformationon
virusinfectivity.
Ultimately,theknowledgegaponinter-human
transmis-sionshouldbefilledbydevelopingandperforming
state-of-the art experiments in a natural setting. Combined
with animal transmission models and air sampling in
different(health care and experimental) settings,these
datashouldresultinathoroughscientificunderstanding
of the inter-human transmission routes of respiratory
viruses. Eventually, this knowledge will help with an
evidence-basedriskassessmentofthedifferent
transmis-sion routes to improve existing infection prevention
strategies.
Acknowledgements
WethankDr.RikdeSwart,Dr.BartHaagmans,Dr.ArnoAndeweg,and Dr.SabrinaSchreinerforhelpfuldiscussions.JKandSHaresupportedby anNWOVIDIgrant(contractnumber91715372),andMS,RFandSHby NIAID/NIHcontractHHSN272201400008C.PFreceivesfundingfromthe EUFP7projectPREPARE(grantnumber602525).Thesponsorshadno roleinthecollection,analysisandinterpretationofdata,inthewritingof thereport,andinthedecisiontosubmitthearticleforpublication.
References
and
recommended
reading
Papersofparticularinterest,publishedwithintheperiodofreview, havebeenhighlightedas:
ofspecialinterest ofoutstandinginterest
1. WHO.Availablefrom:http://www.who.int/en/[cited2017 28.08.17].
2. ChingPH,LiK,Pessoa-SilvaY,SetoCL,WangWTKF:Infection preventionandcontrolofepidemicandpandemic-proneacute respiratorydiseasesinhealthcare:WHOinterimguidelines. Geneva:WHO;2007,90.
3. SiegelJDetal.:2007Guidelineforisolationprecautions: preventingtransmissionofinfectiousagentsinhealthcare settings.AmJInfectControl2007,35(Suppl2):S65-S164.
4. GraltonJetal.:Theroleofparticlesizeinaerosolisedpathogen transmission:areview.JInfect2011,62:1-13.
5. CDC.2017.Availablefrom:https://www.cdc.gov/[cited28.08.17].
6. WeberTP,StilianakisNI:InactivationofinfluenzaAvirusesin theenvironmentandmodesoftransmission:acriticalreview. JInfect2008,57:361-373.
7. MiltonDKetal.:Influenzavirusaerosolsinhumanexhaled breath:particlesize,culturability,andeffectofsurgical masks.PLoSPathog2013,9:e1003205.
8. TellierR:AerosoltransmissionofinfluenzaAvirus:areviewof newstudies.JRSocInterface2009,6(Suppl6):S783-S790.
9. PicaN,BouvierNM:Environmentalfactorsaffectingthe transmissionofrespiratoryviruses.CurrOpinVirol2012, 2:90-95.
10. FernstromA,GoldblattM:Aerobiologyanditsroleinthe transmissionofinfectiousdiseases.JPathog2013, 2013:493960.
11. HerfstSetal.:Driversofairbornehuman-to-humanpathogen transmission.CurrOpinVirol2017,22:22-29.
12. MossWJ,GriffinDE:Measles.Lancet2012,379:153-164.
13. WHO:Measles.2017.Availablefrom:http://www.who.int/ith/ diseases/measles/en/[cited07.08.17].
14.
BlochairborneABtransmissionetal.:Measlesinoutbreakanofficeinsetting.apediatricPediatricspractice:1985, 75:676-683.
Detailedretrospectiveanalysisincluding airflowstudiesofa measles outbreakinapediatricpractice.
15. ChenRTetal.:Anexplosivepoint-sourcemeaslesoutbreakin ahighlyvaccinatedpopulation,modesoftransmissionand riskfactorsfordisease.AmJEpidemiol1989,129:173-182.
16. EhresmannKRetal.:Anoutbreakofmeaslesataninternational sportingeventwithairbornetransmissioninadomedstadium. JInfectDis1995,171:679-683.
17. RileyEC,MurphyG,RileyRL:Airbornespreadofmeaslesina suburbanelementaryschool.AmJEpidemiol1978, 107:421-432.
18.
Remingtonphysician’sPLoffice.etal.:JAirborneAmMedtransmissionAssoc1985,253:1574-1577.ofmeaslesina Detailedretrospectiveanalysisincludingairflowstudiesanda mathema-ticalairbornetransmissionmodelofameaslesoutbreakinaphysician’s office.
19. SteinRA:Super-spreadersininfectiousdiseases.IntJInfect Dis2011,15:e510-e513.
20. LauMSetal.:Spatialandtemporaldynamicsof
superspreadingeventsinthe2014-2015WestAfricaEbola epidemic.ProcNatlAcadSciUSA2017,114:2337-2342.
21. Lloyd-SmithJO,KoppSS,GetzPEWM:Superspreadingandthe effectofindividualvariationondiseaseemergence.Nature 2005,438:355-359.
22. ChristensenPEetal.:Anepidemicofmeaslesinsouthern Greenland,1951;measlesinvirginsoil.II.Theepidemic proper.ActaMedScand1953,144:430-449.
23. CDC:HumanParainfluenzaViruses(HPIVs).2015.Availablefrom: https://www.cdc.gov/parainfluenza/about/transmission.html [cited26.07.17].
24. HenricksonKJ:Parainfluenzaviruses.ClinMicrobiolRev2003, 16:242-264.
25. KarronRA,CollinsPL:Parainfluenzaviruses.In FieldsVirology. EditedbyWoltersKluwerLWW. LippincottWilliams&Wilkins: WoltersKluwer;2013:996-1023.
26. BradyMT,EvansJ,CuartasJ:Survivalanddisinfectionof parainfluenzavirusesonenvironmentalsurfaces.AmJInfect Control1990,18:18-23.
27. AnsariSAetal.:Potentialroleofhandsinthespreadof respiratoryviralinfections:studieswithhumanparainfluenza virus3andrhinovirus14.JClinMicrobiol1991,29:2115-2119. 28. MillerWS,ArtensteinMS:Aerosolstabilityofthreeacute
respiratorydiseaseviruses.ProcSocExpBiolMed1967, 125:222-227.
29. McLeanDM,BannatyneRM,GivanKF:Myxovirusdissemination byair.CanMedAssocJ1967,96:1449-1453.
30. TollefsonSJ,CoxRG,WilliamsJV:Studiesofcultureconditions andenvironmentalstabilityofhumanmetapneumovirus.Virus Res2010,151:54-59.
31. HallCB,Douglas RGJr:Modesoftransmissionofrespiratory syncytialvirus.JPediatr1981,99:100-103.
32.
HallfomitesCB,ofDouglasrespiratoryRGJr,syncytialGeimanvirus.JM:PossibleJInfectDistransmission1980,141:98-by 102.
StudyinwhichtransmissionmodesofRSVbetweeninfantsandadults wereinvestigated.
33. AintablianN,WalpitaP,SawyerMH:DetectionofBordetella pertussisandrespiratorysynctialvirusinairsamplesfrom hospitalrooms.InfectControlHospEpidemiol1998,19:918-923. 34.
Kulkarnibyaerosol,Hettimeal.:Evidencetorevisitofinfectionrespiratorycontrolsyncytialstrategies?virusspreadAmJ RespirCritCareMed2016,194:308-316.
Air-sampling study ina children’shospital in which viable RSV was collectedfromtheair.
35. Gwaltney JMJr,HendleyJO:Transmissionofexperimental rhinovirusinfectionbycontaminatedsurfaces.AmJEpidemiol 1982,116:828-833.
36. Gwaltney JMJr,MoskalskiPB,HendleyJO:Hand-to-hand transmissionofrhinoviruscolds.AnnInternMed1978, 88:463-467.
37. MyattTAetal.:Detectionofairbornerhinovirusanditsrelation tooutdoorairsupplyinofficeenvironments.AmJRespirCrit CareMed2004,169:1187-1190.
38.
MeschievitzpredictableCK,naturalSchultztransmissionSB,DickEC:ofrhinovirusesAmodelforinobtaininghuman volunteers.JInfectDis1984,150:195-201.
Inthisstudytheimportanceofexposuretimeinhumantransmission experimentswasdemonstrated.
39.
DickamongEChumanetal.:Interruptionvolunteersofusingtransmissionvirucidalpaperofrhinoviruscolds handkerchiefs.JInfectDis1986,153:352-356.
Inthisstudytheminiaturefieldtrialwasusedtodiscriminatebetween aerosolandindirectcontacttransmission.
40. DickECetal.:Aerosoltransmissionofrhinoviruscolds.JInfect Dis1987,156:442-448.
41. CateTRetal.:Productionoftracheobronchitisinvolunteers withrhinovirusinasmall-particleaerosol.AmJEpidemiol 1965,81:95-105.
42. HendleyJO,WenzelRP,Gwaltney JMJr:Transmissionof rhinoviruscoldsbyself-inoculation.NEnglJMed1973, 288:1361-1364.
43. ReedSE:Aninvestigationofthepossibletransmissionof Rhinoviruscoldsthroughindirectcontact.JHyg(Lond)1975, 75:249-258.
44. PancicF,CarpentierDC,CamePE:Roleofinfectioussecretions inthetransmissionofrhinovirus.JClinMicrobiol1980, 12:567-571.
45. BrankstonGetal.:TransmissionofinfluenzaAinhuman beings.LancetInfectDis2007,7:257-265.
46. LeeRV:TransmissionofinfluenzaAinhumanbeings.Lancet InfectDis2007,7:761-763760-1;authorreply.
47. LemieuxCetal.:Questioningaerosoltransmissionof influenza.EmergInfectDis2007,13(1):173-174authorreply 174-5.
48. TellierR:TransmissionofinfluenzaAinhumanbeings.Lancet InfectDis2007,7:759-760authorreply761-3.
49. TellierR:ReviewofaerosoltransmissionofinfluenzaAvirus. EmergInfectDis2006,12:1657-1662.
50. KillingleyB,Nguyen-Van-TamJ:Routesofinfluenza
transmission.InfluenzaOtherRespirViruses2013,7(Suppl 2):42-51.
51.
LittleintranasalJWetinoculation.al.:AttenuatedJMedinfluenzaVirol1979,produced3:177-188.byexperimental Authorscomparednaturalandexperimentallyinducedinfluenza infec-tionsbyassessingclinicalillnessandpulmonaryfunction.
52. AlfordRHetal.:Humaninfluenzaresultingfromaerosol inhalation.ProcSocExpBiolMed1966,122:800-804.
53. HenleW,HenleGetal.:Experimentalexposureofhuman subjectstovirusesofinfluenza.JImmunol1946,52:145-165. 54. SmorodintseffAAT,DrobyshevskayaMD,KorovinAI,
OsetroffAAAI:Investigationonvolunteersinfectedwiththe influenzavirus.AmJMedSci1937,194:159-170.
55. BischoffWEetal.:Exposuretoinfluenzavirusaerosolsduring routinepatientcare.JInfectDis2013,207:1037-1046. 56. FabianPetal.:Influenzavirusinhumanexhaledbreath:an
observationalstudy.PLoSONE2008,3:e2691.
57.
LindsleyexpelledWGduringetal.:coughsViableinfluenzaversusexhalations.AvirusinairborneInfluenzaparticlesOther RespirViruses2016,10:404-413.
Authorscomparedthegenerationofaerosolsladenwithviableinfluenza virusduringcoughingandexhalationofinfectedindividuals.
58. LindsleyWGetal.:Measurementsofairborneinfluenzavirusin aerosolparticlesfromhumancoughs.PLoSONE2010,5: e15100.
59. LednickyJA,LoebJC:Detectionandisolationofairborne influenzaAH3N2virususingasioutaspersonalcascade impactorsampler.InfluenzaResTreat2013,2013:656825.
60. BlachereFMetal.:Measurementofairborneinfluenzavirusina hospitalemergencydepartment.ClinInfectDis2009,48: 438-440.
61. LindsleyWGetal.:Distributionofairborneinfluenzavirusand respiratorysyncytialvirusinanurgentcaremedicalclinic.Clin InfectDis2010,50:693-698.
62. AdamsMJetal.:ChangestotaxonomyandtheInternational CodeofVirusClassificationandNomenclatureratifiedbythe InternationalCommitteeonTaxonomyofViruses(2017).Arch Virol2017.
63. MastersPS,PerlmanS:Coronaviridae.In Fieldsvirology.Edited byKnipeHDMPM. WoltersKluwer,LippcottWilliams&Wilkins; 2007:825-858.
64. GagneurAetal.:Coronavirus-relatednosocomialviral respiratoryinfectionsinaneonatalandpaediatricintensive careunit:aprospectivestudy.JHospInfect2002,51:59-64.
65. SizunJ,YuMW,TalbotPJ:Survivalofhumancoronaviruses 229EandOC43insuspensionandafterdryingonsurfaces:a possiblesourceofhospital-acquiredinfections.JHospInfect 2000,46:55-60.
66. MullerAetal.:Stabilityofhumanmetapneumovirusandhuman coronavirusNL63onmedicalinstrumentsandinthepatient environment.JHospInfect2008,69:406-408.
67. RabenauHFetal.:StabilityandinactivationofSARS coronavirus.MedMicrobiolImmunol(Berl)2005,194:1-6. 68. IjazMKetal.:Survivalcharacteristicsofairbornehuman
69. OtterJAetal.:TransmissionofSARSandMERScoronaviruses andinfluenzavirusinhealthcaresettings:thepossibleroleof drysurfacecontamination.JHospInfect2016,92:235-250.
70. DuanSMetal.:StabilityofSARScoronavirusinhuman specimensandenvironmentanditssensitivitytoheatingand UVirradiation.BiomedEnvironSci2003,16:246-255.
71. ChowellGetal.:TransmissioncharacteristicsofMERSand SARSinthehealthcaresetting:acomparativestudy.BMCMed 2015,13:210.
72. LeeNetal.:Amajoroutbreakofsevereacuterespiratory syndromeinHongKong.NEnglJMed2003,348:1986-1994.
73. OfnerMetal.:Clusterofsevereacuterespiratorysyndrome casesamongprotectedhealth-careworkers–Toronto, Canada,April(ReprintedfromMMWR,vol.52,pg433–436, 2003).JAmMedAssoc2003,289:2788-2789.
74. GamageBetal.:ProtectinghealthcareworkersfromSARS andotherrespiratorypathogens:areviewoftheinfection controlliterature.AmJInfectControl2005,33:114-121.
75. WongGetal.:MERS,SARS,andEbola:theroleof super-spreadersininfectiousdisease.CellHostMicrobe2015, 18:398-401.
76. BradenCRetal.:Progressinglobalsurveillanceandresponse capacity10yearsaftersevereacuterespiratorysyndrome. EmergInfectDis2013,19:864-869.
77. ShenZetal.:SuperspreadingSARSevents,Beijing,2003. EmergInfectDis2004,10:256-260.
78.
WongexposedTWtoetsingleal.:Clusterpatient,ofSARSHongKong.amongEmergmedicalInfectstudentsDis2004, 10:269-276.
AuthorsdemonstrateSARS-CoVtransmissioninhealthcareworkersand alinkwithproximitytotheindexcase.
79.
acuteVariaMrespiratoryetal.:Investigationsyndromeof(SARS)anosocomialinToronto,outbreakCanada.ofsevereCMAJ 2003,169:285-292.
AuthorsdescribetheriskofSARS-CoVtransmissionregardingdistance andaerosol-generatingproceduresduringanosocomialoutbreak.
80. BoothTFetal.:Detectionofairbornesevereacuterespiratory syndrome(SARS)coronavirusandenvironmental
contaminationinSARSoutbreakunits.JInfectDis2005, 191:1472-1477.
81. PoutanenSM,McGeerAJ:TransmissionandcontrolofSARS. CurrInfectDisRep2004,6:220-227.
82. YuITetal.:Evidenceofairbornetransmissionofthesevere acuterespiratorysyndromevirus.NEnglJMed2004, 350:1731-1739.
83. ShapiroMetal.:MiddleEastrespiratorysyndrome coronavirus:reviewofthecurrentsituationintheworld. DisasterMilMed2016,2:9.
84. vanDoremalenN,BushmakerT,MunsterVJ:StabilityofMiddle Eastrespiratorysyndromecoronavirus(MERS-CoV)under differentenvironmentalconditions.EuroSurveill2013,18.
85. HunterJCetal.:Transmissionofmiddleeastrespiratory syndromecoronavirusinfectionsinhealthcaresettings,Abu Dhabi.EmergInfectDis2016,22:647-656.
86. ObohoIKetal.:2014MERS-CoVoutbreakinJeddah–alinkto healthcarefacilities.NEnglJMed2015,372:846-854.
87. AssiriAetal.:HospitaloutbreakofMiddleEastrespiratory syndromecoronavirus.NEnglJMed2013,369:407-416.
88. GueryBetal.:Clinicalfeaturesandviraldiagnosisoftwocases ofinfectionwithMiddleEastRespiratorySyndrome coronavirus:areportofnosocomialtransmission.Lancet 2013,381:2265-2272.
89. OhMDetal.:Middleeastrespiratorysyndromecoronavirus superspreadingeventinvolving81persons,Korea.JKorean MedSci2015,30:1701-1705.
90. BinSYetal.:Environmentalcontaminationandviralshedding inMERSpatientsduringMERS-CoVoutbreakinSouthKorea. ClinInfectDis2016,62:755-760.
91.
KimsyndromeSHetal.:(MERS)Extensivecoronavirusviablemiddlecontaminationeastrespiratoryinairand surroundingenvironmentinMERSisolationwards.ClinInfect Dis2016,63:363-369.
FirsttimethatMERS-CoVwasdemonstratedinairsamplesfrom out-break units. Virus was also detectedon fomites and environmental surfaces.
92. MusherDM:Howcontagiousarecommonrespiratorytract infections? NEnglJMed2003,348:1256-1266.
93. ScottMKetal.:Humanadenovirusassociatedwithsevere respiratoryinfection,Oregon,USA,2013–2014.EmergInfect Dis2016,22:1044-1051.
94. BerkAJ:Adenoviridae.In Fieldsvirology.EditedbyKnipe HDMPM. LippincottWilliams&Wilkins:WoltersKluwer;2013: 1704-1731.
95. HatherillMetal.:Evolutionofanadenovirusoutbreakina multidisciplinarychildren’shospital.JPaediatrChildHealth 2004,40:449-454.
96. PalominoMA,LarranagaC,AvendanoLF:Hospital-acquired adenovirus7hinfantilerespiratoryinfectioninChile.Pediatr InfectDisJ2000,19:527-531.
97. JamesLetal.:Outbreakofhumanadenovirustype3infection inapediatriclong-termcarefacility–Illinois,2005.ClinInfect Dis2007,45:416-420.
98. PorterJDetal.:Outbreakofadenoviralinfectionsina long-termpaediatricfacility,NewJersey,1986/87.JHospInfect 1991,18:201-210.
99. HillemanMR:Epidemiologyofadenovirusrespiratory infectionsinmilitaryrecruitpopulations.AnnNYAcadSci 1957,67:262-272.
100.ForgieS,MarrieTJ:Healthcare-associatedatypical pneumonia.SeminRespirCritCareMed2009,30:67-85.
101.KlingerJRetal.:Multiplecasesoflife-threateningadenovirus pneumoniainamentalhealthcarecenter.AmJRespirCritCare Med1998,157:645-649.
102.CouchRBetal.:Aerosol-inducedadenoviralillnessresembling thenaturallyoccurringillnessinmilitaryrecruits.AmRev RespirDis1966,93:529-535.
103.
EchavarrianegativeenvironmentalMetal.:DetectionsamplesofadenovirusesbyPCRduring(AdV)aninAdV- culture-associatedrespiratorydiseaseoutbreak.JClinMicrobiol2000, 38:2982-2984.
AuthorsshowalinkbetweenadenovirusDNAinairfiltersand adenovirus-relatedhospitalizations.
104.RussellKLetal.:Transmissiondynamicsandprospective environmentalsamplingofadenovirusinamilitaryrecruit setting.JInfectDis2006,194:877-885.
105.ThomsonFH,PriceC:Theaerialconveyanceofinfection. Lancet1914:1669-1673.
106.LeavyO:Infectiousdisease:thetoleranceofsuperspreaders. NatRevImmunol2014,14:776-777.
107.ChristianMDetal.:PossibleSARScoronavirustransmission duringcardiopulmonaryresuscitation.EmergInfectDis2004, 10:287-293.
108.WIP:W.i.p.Ziekenhuizen:indicatievoorisolatie.2006–2013. Availablefrom: http://www.rivm.nl/dsresource?objectid=6642621a-52da-4cd0-96c7-58bea053b380&type=org&disposition=inline[cited 01.11.17].
109.SharlandM,ButlerK,GiaquintoC,FinnA,EspositoS, GalanakisM:Manualofchildhoodinfections:thebluebook.edn4. OxfordUniversityPress;2016.
110.PickeringLK,BakerCJ,KimberlinDW,LongSH:Redbook: 2012reportofthecommitteeoninfectiousdiseases.edn29. Elk GroveVilage:AmericanAcademyofPediatrics;2012.
111.UpToDate.2017.Availablefrom:https://www.uptodate.com/ [cited20.10.17].
112.
assessKillingleyperson-to-personBetal.:Useofahumantransmission:influenzaproof-of-conceptchallengemodelto study.JInfectDis2012,205:35-43.
Ahumanproof-of-conceptstudy,inwhichauthorsassessedinfectivity rateofexperimentallyinoculatedvolunteersandsecondaryattackrate amongsusceptibleindividuals.
113.LowenACetal.:Influenzavirustransmissionisdependenton relativehumidityandtemperature.PLoSPathog2007, 3:1470-1476.
114.BelserJAetal.:Complexitiesinferretinfluenzavirus pathogenesisandtransmissionmodels.MicrobiolMolBiolRev 2016,80:733-744.
115.CDC:Interiminfectionpreventionandcontrolrecommendations forhospitalizedpatientswithMiddleEastRespiratorySyndrome Coronavirus(MERS-CoV).2015.Availablefrom:https://www.cdc. gov/coronavirus/mers/infection-prevention-control.html[cited 13.11.17].
116.KnightV:Virusesasagentsofairbornecontagion.AnnNYAcad Sci1980,353:147-156.
117.SetoWHetal.:Effectivenessofprecautionsagainstdroplets andcontactinpreventionofnosocomialtransmissionof severeacuterespiratorysyndrome(SARS).Lancet2003, 361:1519-1520.
118.OlsenSJetal.:Transmissionofthesevereacuterespiratory syndromeonaircraft.NEnglJMed2003,349:2416-2422. 119.D’AlessioDJetal.:Transmissionofexperimentalrhinovirus
coldsinvolunteermarriedcouples.JInfectDis1976,133:28-36. 120.AditamaTYetal.:AvianinfluenzaH5N1transmissionin
households,Indonesia.PLoSONE2012,7:e29971. 121.HallCBetal.:Respiratorysyncytialvirusinfectionswithin
families.NEnglJMed1976,294:414-419.
122.ChuHYetal.:Nosocomialtransmissionofrespiratorysyncytial virusinanoutpatientcancercenter.BiolBloodMarrowTranspl 2014,20:844-851.
123.LauJTetal.:Probablesecondaryinfectionsinhouseholdsof SARSpatientsinHongKong.EmergInfectDis2004, 10:235-243.
124.ColemanKP,MarkeyPG:Measlestransmissioninimmunized andpartiallyimmunizedairtravellers.EpidemiolInfect2010, 138:1012-1015.
125.AmornkulPNetal.:Lowriskofmeaslestransmissionafter exposureonaninternationalairlineflight.JInfectDis2004,189 (Suppl1):S81-S85.
126.NeatherlinJetal.:InfluenzaA(H1N1)pdm09duringairtravel. TravelMedInfectDis2013,11:110-118.
127.ShankarAGetal.:ContacttracingforinfluenzaA(H1N1)pdm09 virus-infectedpassengeroninternationalflight.EmergInfect Dis2014,20:118-120.
128.CowlingBJetal.:Facemasksandhandhygienetoprevent influenzatransmissioninhouseholds:aclusterrandomized trial.AnnInternMed2009,151:437-446.
129.SimmermanJMetal.:Findingsfromahouseholdrandomized controlledtrialofhandwashingandfacemaskstoreduce influenzatransmissioninBangkok,Thailand.InfluenzaOther RespirViruses2011,5:256-267.
130.AllisonMAetal.:Feasibilityofelementaryschoolchildren’suse ofhandgelandfacemasksduringinfluenzaseason.Influenza OtherRespirViruses2010,4:223-229.
131.HaydenGF,HendleyJO,Gwaltney JMJr:Theeffectofplacebo andvirucidalpaperhandkerchiefsonviralcontaminationof thehandandtransmissionofexperimentalrhinoviral infection.JInfectDis1985,152:403-407.
132.KaiserLetal.:Short-termtreatmentwithzanamivirtoprevent influenza:resultsofaplacebo-controlledstudy.ClinInfectDis 2000,30:587-589.
133.BischoffWEetal.:DetectionofmeaslesvirusRNAinairand surfacespecimensinahospitalsetting.JInfectDis2016, 213:600-603.
134.LidwellOM,TowersAG:Protectionfrommicrobial contaminationinaroomventilatedbyauni-directionalair flow.JHyg(Lond)1969,67:95-106.
135.NormileD:TheMetropole,superspreaders,andother mysteries.Science2013,339:1272-1273.
136.BeggsCB,ShepherdSJ,KerrKG:Potentialforairborne transmissionofinfectioninthewaitingareasofhealthcare premises:stochasticanalysisusingaMonteCarlomodel. BMCInfectDis2010,10:247.
137.NicasM,JonesRM:Relativecontributionsoffourexposure pathwaystoinfluenzainfectionrisk.RiskAnal2009, 29:1292-1303.
138.WagnerBG,CoburnBJ,BlowerS:Calculatingthepotentialfor within-flighttransmissionofinfluenzaA(H1N1).BMCMed 2009,7:81.
139.NicasM,BestD:Astudyquantifyingthehand-to-facecontact rateanditspotentialapplicationtopredictingrespiratorytract infection.JOccupEnvironHyg2008,5:347-352.
140.TangJWetal.:Factorsinvolvedintheaerosoltransmissionof infectionandcontrolofventilationinhealthcarepremises.J HospInfect2006,64:100-114.
141.ChowellGetal.:Synthesizingdataandmodelsforthespreadof MERS-CoV.2013,keyroleofindexcasesandhospital transmission.Epidemics2014,9:40-51.